Jacobio Pharmaceuticals Group Co Ltd
HKEX:1167
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1.44
3.87
|
| Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Jacobio Pharmaceuticals Group Co Ltd
Jacobio Pharmaceuticals Group Co Ltd
Research & Development
Jacobio Pharmaceuticals Group Co Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Jacobio Pharmaceuticals Group Co Ltd
HKEX:1167
|
Research & Development
-¥363.7m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-35%
|
CAGR 10-Years
N/A
|
|
|
Beigene Ltd
HKEX:6160
|
Research & Development
-¥12.5B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
|
Akeso Inc
HKEX:9926
|
Research & Development
-¥1.3B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-51%
|
CAGR 10-Years
N/A
|
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Research & Development
-¥1.1B
|
CAGR 3-Years
-54%
|
CAGR 5-Years
-54%
|
CAGR 10-Years
N/A
|
|
|
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
|
Research & Development
-¥192.9m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Research & Development
-¥1B
|
CAGR 3-Years
-47%
|
CAGR 5-Years
-45%
|
CAGR 10-Years
N/A
|
|
Jacobio Pharmaceuticals Group Co Ltd
Glance View
Jacobio Pharmaceuticals Group Co., Ltd. operates as an investment holding company which engages in research and development of new drugs. The company is headquartered in Beijing, Beijing. The company went IPO on 2020-12-21. The firm is primarily responsible for the independent discovery and development of innovative tumor therapies. The firm's main drug development projects include JAB-3068 and JAB-3312 clinical stage allosteric SHP2 inhibitors. The firm mainly conducts business within the domestic market.
See Also
What is Jacobio Pharmaceuticals Group Co Ltd's Research & Development?
Research & Development
-363.7m
CNY
Based on the financial report for Dec 31, 2023, Jacobio Pharmaceuticals Group Co Ltd's Research & Development amounts to -363.7m CNY.
What is Jacobio Pharmaceuticals Group Co Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
-35%
Over the last year, the Research & Development growth was 17%. The average annual Research & Development growth rates for Jacobio Pharmaceuticals Group Co Ltd have been -26% over the past three years , -35% over the past five years .
You don't have any saved screeners yet
